Invivogen
Menu

Anti-hCD20-hIgG2

Anti-hCD20-hIgG2 Unit size Cat. code Docs Qty Price
Human CD20 (rituximab) antibody - Human IgG2
100 µg
hcd20-mab2
+-
$315.00

Monoclonal human IgG2 antibody against human CD20

Anti-hCD20-hIgG2 features the constant region of the human IgG2 isotype and the variable region of rituximab.

Rituximab is a mouse/human chimeric monoclonal antibody that targets the CD20 antigen found on the surface of malignant and normal B lymphocytes.

Binding of rituximab to CD20 results in cell destruction through different mechanisms including direct signaling of apoptosis, complement activation and cell-mediated cytotoxicity.

Rituximab has been approved by the FDA for the treatment of various lymphoid malignancies, including B-cell non-Hodgkin's lymphoma and B-cell chronic lymphocytic leukaemia.

Anti-hCD20-hIgG2 was generated by recombinant DNA technology. It has been produced in CHO cells and purified by affinity chromatography with protein G.

Back to the top

Specifications

Clonality: Monoclonal antibody

Specificity: Targets cells expressing human CD20

Isotype: Human IgG2

Back to the top

Contents

  • 100 µg purified anti-hCD20-hIgG2 antibody, provided azide-free and lyophilized.

room temperature Product is shipped at room temperature.

store Store lyophilized antibody at -20°C.

stabilityLyophilized product is stable for 1 year.

Back to the top

Citations

Customer Service
& Technical Support
Shopping cart is empty